UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunogenic HSV-mediated Oncolysis Shapes the Antitumor Immune Response and Contributes to Therapeutic Efficacy

Molecular therapy, 2014-01, Vol.22 (1), p.123-131

2014

Volltextzugriff (PDF)

A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine

PloS one, 2011-03, Vol.6 (3), p.e17748

2011

Volltextzugriff (PDF)

Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2

PloS one, 2015-12, Vol.10 (12), p.e0145228-e0145228

2015

Volltextzugriff (PDF)

Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine

PloS one, 2015-02, Vol.10 (2), p.e0116091-e0116091

2015

Volltextzugriff (PDF)

Pan-HSV-2 IgG antibody in vaccinated mice and guinea pigs correlates with protection against herpes simplex virus 2

PloS one, 2013-06, Vol.8 (6), p.e65523-e65523

2013

Volltextzugriff (PDF)

The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious Virions

PloS one, 2015-06, Vol.10 (6), p.e0131420-e0131420

2015

Volltextzugriff (PDF)

Herpes simplex virus 2 ICP0 mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccine

PloS one, 2010-08, Vol.5 (8), p.e12251

2010

Volltextzugriff (PDF)

ICP0 dismantles microtubule networks in herpes simplex virus-infected cells

PloS one, 2010-06, Vol.5 (6), p.e10975-e10975

2010

Volltextzugriff (PDF)

The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization

PLoS pathogens, 2011-10, Vol.7 (10), p.e1002278-e1002278

2011

Volltextzugriff (PDF)

Alpha/Beta Interferon and Gamma Interferon Synergize To Inhibit the Replication of Herpes Simplex Virus Type 1

Journal of Virology, 2002-11, Vol.76 (22), p.11541-11550

2002

Volltextzugriff (PDF)

A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter

PloS one, 2015-03, Vol.10 (3), p.e0122253

2015

Volltextzugriff (PDF)

Loss of the Type I Interferon Pathway Increases Vulnerability of Mice to Genital Herpes Simplex Virus 2 Infection

Journal of Virology, 2011-02, Vol.85 (4), p.1625-1633

2011

Volltextzugriff (PDF)

Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012

PloS one, 2015-01, Vol.10 (1), p.e114989-e114989

2015

Volltextzugriff (PDF)

Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?

Expert review of vaccines, 2014-06, Vol.13 (6), p.691-710

Halford, William P

2014

Volltextzugriff (PDF)

ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency

Virology journal, 2006-06, Vol.3 (1), p.44-44

2006

Volltextzugriff (PDF)

Investigation of the Mechanism by Which Herpes Simplex Virus Type 1 LAT Sequences Modulate Preferential Establishment of Latent Infection in Mouse Trigeminal Ganglia

Journal of Virology, 2009-08, Vol.83 (16), p.7873-7882

2009

Volltextzugriff (PDF)

Re-Evaluating Natural Resistance to Herpes Simplex Virus Type 1

Journal of Virology, 2004-09, Vol.78 (18), p.10086-10095

2004

Volltextzugriff (PDF)

ICP0 antagonizes ICP4-dependent silencing of the herpes simplex virus ICP0 gene

PloS one, 2010-01, Vol.5 (1), p.e8837-e8837

2010

Volltextzugriff (PDF)

HSV-1 latent rabbits shed viral DNA into their saliva

Virology journal, 2012-09, Vol.9 (1), p.221-221, Article 221

2012

Volltextzugriff (PDF)

Subtle CXCR3-Dependent Chemotaxis of CTLs within Infected Tissue Allows Efficient Target Localization

The Journal of immunology (1950), 2015-12, Vol.195 (11), p.5285-5295

2015

Volltextzugriff (PDF)

The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa

The Journal of immunology (1950), 2017-09, Vol.199 (5), p.1898-1911

2017

Volltextzugriff (PDF)

A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity

Journal of virology, 2016-06, Vol.90 (11), p.5514-5529

2016

Volltextzugriff (PDF)

Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells

The FASEB journal, 2005-03, Vol.19 (3), p.440-442

2005

Volltextzugriff (PDF)

Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice

Journal of virology, 2017-04, Vol.91 (7)

2017

Volltextzugriff (PDF)

Nuclear double-fluorescent reporter for in vivo and ex vivo analyses of biological transitions in mouse nuclei

Mammalian genome, 2013-10, Vol.24 (9-10), p.389-399

2013

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(98)
Bücher
(1)

Sprache

Englisch
(99)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Life Sciences & Biomedicine
(56)
Animals
(54)
Mice
(39)
Humans
(32)
Female
(29)
Virology
(28)
Immunology
(27)
Herpes Simplex Virus 1
(20)
Viruses
(17)
Multidisciplinary Sciences
(16)
Science & Technology - Other Topics
(16)
Vero Cells
(16)
Cercopithecus Aethiops
(15)
Herpes Viruses
(15)
Herpesvirus 1, Human - Genetics
(15)
Trigeminal Ganglion - Virology
(15)
Vaccines
(15)
Herpes Simplex - Virology
(14)
Herpesvirus 1, Human - Immunology
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunogenic HSV-mediated Oncolysis Shapes the Antitumor Immune Response and Contributes to Therapeutic Efficacy

A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine

Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2

Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine

Pan-HSV-2 IgG antibody in vaccinated mice and guinea pigs correlates with protection against herpes simplex virus 2

The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious Virions

Herpes simplex virus 2 ICP0 mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccine

ICP0 dismantles microtubule networks in herpes simplex virus-infected cells

The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization

Alpha/Beta Interferon and Gamma Interferon Synergize To Inhibit the Replication of Herpes Simplex Virus Type 1

A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter

Loss of the Type I Interferon Pathway Increases Vulnerability of Mice to Genital Herpes Simplex Virus 2 Infection

Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012

Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?

ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency

Investigation of the Mechanism by Which Herpes Simplex Virus Type 1 LAT Sequences Modulate Preferential Establishment of Latent Infection in Mouse Trigeminal Ganglia

Re-Evaluating Natural Resistance to Herpes Simplex Virus Type 1

ICP0 antagonizes ICP4-dependent silencing of the herpes simplex virus ICP0 gene

HSV-1 latent rabbits shed viral DNA into their saliva

Subtle CXCR3-Dependent Chemotaxis of CTLs within Infected Tissue Allows Efficient Target Localization

The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa

A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity

Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells

Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice

Nuclear double-fluorescent reporter for in vivo and ex vivo analyses of biological transitions in mouse nuclei

Suchergebnisse filtern